Today, on December 6, SciLifeLab welcomed Nobel Laureate Sir Gregory P. Winter to its Stockholm site. Professor Winter is a biochemist of the University of Cambridge, UK, and awarded this year’s Nobel Prize for his work on phage-display for antibodies.

Phage display is a laboratory technique where a bacteriophage, a virus that infects bacteria, is used to develop new proteins. Gregory Winter has used phage display for the directed evolution of antibodies, with the aim of producing new pharmaceuticals.

During his SciLifeLab visit, hosted by Mathias Uhlén (KTH/SciLifeLab), Gregory Winter met with a group of researchers who presented their work in areas such as The Human Protein Atlas, monitoring of biomarkers and biopharmaceutical therapy of Alzheimer’s disease. Among others, Helena Persson Lotsholm (KTH), Head of the Human Antibody Therapeutics facility at SciLifeLab, gave a talk on the phage display work that the facility conducts to support researchers across Sweden in developing therapeutic antibodies.

“We are honoured by the visit of Nobel Laureate Gregory Winter. His ground-breaking research has revolutionised the field of biological drugs and it has led to new therapies in medical practice. SciLifeLab is using the technology developed by his group in several facilities both in Stockholm and Lund”, says Mathias Uhlén, who is also the KTH SciLifeLab Integration Director.

Gregory Winter shares the 2018 Nobel Prize in Chemistry with George Smith and Frances Arnold.